Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» basal cell carcinoma
basal cell carcinoma
Verrica stock drops after half patients’ tumours gone in skin cancer trial
Clinical Trials Arena
Thu, 08/15/24 - 11:45 am
Verrica Pharmaceuticals
basal cell carcinoma
clinical trials
Turn Therapeutics Announces Positive In-Vivo Data for Non-Melanoma Skin Cancer Candidate
BioSpace
Wed, 07/13/22 - 10:10 am
Turn Therapeutics
clinical trials
GX-03
basal cell carcinoma
skin cancer
Sanofi and Regeneron's I-O med Libtayo, on a roll, puts up basal cell carcinoma win
Fierce Pharma
Tue, 05/5/20 - 12:59 pm
Sanofi
Regeneron
Libtayo
basal cell carcinoma
skin cancer
clinical trials
FDA OK's Odomzo from Novartis for common skin cancer type
Yahoo/AP
Sat, 07/25/15 - 09:41 am
FDA
Odomzo
Novartis
basal cell carcinoma
skin cancer
New Drugs Treat Advanced Stages of a Common Skin Cancer
WSJ Pharmalot
Tue, 11/25/14 - 10:58 am
basal cell carcinoma
Erivedge
Genentech
Can Stopping This Hedgehog Create New Cancer Treatments?
Motley Fool
Tue, 09/10/13 - 11:30 am
hedgehog pathway inhibitor
Curis
Roche
basal cell carcinoma
Erivedge
Conditional European Approval for Roche's Erivedge
Yahoo/Zacks
Thu, 07/18/13 - 10:20 am
Roche
Erivedge
Europe
basal cell carcinoma
Curis Operable BCC Human Data: Early Results And Further Commentary
Seeking Alpha
Sun, 04/15/12 - 12:23 pm
Erivedge
Curis
Roche
basal cell carcinoma
Curis Earns $8 Million Milestone As NDA Accepted By FDA
Seeking Alpha
Thu, 11/10/11 - 01:08 pm
Curis
milestone payments
FDA
basal cell carcinoma
Genentech
vismodegib
FDA gives priority to Roche skin cancer drug vismodegib
Pharma Times, UK
Wed, 11/9/11 - 12:07 pm
Roche
vismodegib
FDA
skin cancer
basal cell carcinoma
hedgehog pathway inhibitor
Roche’s Vismodegib Meets Main Goal of Advanced Skin-Cancer Study
Bloomberg
Sat, 09/24/11 - 12:43 pm
vismodegib
Roche
basal cell carcinoma
skin cancer
Curis: Next Week's Data Release Could Bring Volatility to Shares
Seeking Alpha
Sat, 06/18/11 - 10:02 am
Curis
basal cell carcinoma
hedgehog pathway inhibitor